979
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination

ORCID Icon, , , , , , , , & show all
Pages 2106-2111 | Received 06 Dec 2018, Accepted 04 Feb 2019, Published online: 15 Mar 2019

References

  • Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008;371(9616):932–44. doi:10.1016/S0140-6736(08)60419-5.
  • Ma C, Hao LX, Su QR, Wen N, Fan CX, Yang H, Wang HQ, Li L. Vaccination schedules, reported vaccination coverage rates, and incidences of measles, mumps and rubella of the 194 member states of the world health organization. Chin J Vaccines Immunization. 2015;21(3):241–7+254. (In Chinese).
  • Cardemil CV, Dahl RM, James L, Wannemuehler K, Gary HE, Shah M, Marin M, Riley J, Feikin DR, Patel M, et al. Effectiveness of a third dose of MMR vaccine for mumps outbreak control. N Engl J Med. 2017;377(10):947–56. doi:10.1056/NEJMoa1703309.
  • Lewnard JA, Grad YH. Vaccine waning and mumps re-emergence in the United States. Sci Transl Med. 2018;10(433):S25. doi:10.1126/scitranslmed.aao4496.
  • Beleni AI, Borgmann S. Mumps in the vaccination age: global epidemiology and the situation in Germany. Int J Environ Res Public Health. 2018;15(8):1618. doi:10.3390/ijerph15061188.
  • Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. Br Med J. 2005;330(7500):1132–35. doi:10.1136/bmj.330.7500.1132.
  • Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O’Keefe AL, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580–89. doi:10.1056/NEJMoa0706589.
  • Domínguez A, Torner N, Castilla J, Batalla J, Godoy P, Guevara M, Carnicer D, Caylà J, Rius C, Jansà JM. Mumps vaccine effectiveness in highly immunized populations. Vaccine. 2010;28(20):3567–70. doi:10.1016/j.vaccine.2010.02.107.
  • Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel’s highly vaccinated society: are two doses enough. Epidemiol Infect. 2012;140(3):439–46. doi:10.1017/S095026881100063X.
  • Cui A, Zhu Z, Hu Y, Deng X, Sun Z, Zhang Y, Mao N, Xu S, Fang X, Gao H, et al. Mumps epidemiology and mumps virus genotypes circulating in mainland China during 2013–2015. PLoS One. 2017;12(1):e0169561. doi:10.1371/journal.pone.0169561.
  • Cui A, Zhu Z, Mao N, Si Y, Ma Y, Hu Y, Deng X, Wang L, Zeng L, Zhang Y, et al. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China. Vaccine. 2018;36(38):5725–31. doi:10.1016/j.vaccine.2018.08.028.
  • Wang H, Hu Y, Zhang G, Zheng J, Li L, An Z. Meta-analysis of vaccine effectiveness of mumps-containing vaccine under different immunization strategies in China. Vaccine. 2014;32(37):4806–12. doi:10.1016/j.vaccine.2014.05.061.
  • Davidkin I, Kontio M, Paunio M, Peltola H. MMR vaccination and disease elimination: the finnish experience. Expert Rev Vaccines. 2010;9(9):1045–53. doi:10.1586/erv.10.99.
  • Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999;77(1):3–14.
  • Slater PE, Anis E, Leventhal A. The control of mumps in Israel. Eur J Epidemiol. 1999;15(8):765–67.
  • Ma R, Lu L, Zhou T, Pan J, Chen M, Pang X. Mumps disease in Beijing in the era of two-dose vaccination policy, 2005–2016. Vaccine. 2018;36(19):2589–95. doi:10.1016/j.vaccine.2018.03.074.
  • Man W, Jin-Kou Z, Tao W, Li-Xin H, Chao M, Qi-Ru S, Hui-Ming L. Mumps-containing vaccine effectiveness during outbreaks in two schools in Guangdong, China, 2012. Western Pac Surveill Response J. 2012;3(4):29–32. doi:10.5365/WPSAR.2012.3.4.012.
  • Ma C, Liu Y, Tang J, Jia H, Qin W, Su Y, Wang H, Hao L. Assessment of mumps-containing vaccine effectiveness during an outbreak: importance to introduce the 2-dose schedule for China. Hum Vaccin Immunother. 2018;14(6):1392–97. doi:10.1080/21645515.2018.1428508.
  • Sugg WC, Finger JA, Levine RH, Pagano JS. Field evaluation of live virus mumps vaccine. J Pediatr. 1968;72(4):461–66.
  • Hilleman MR, Weibel RE, Buynak EB, Stokes J, Whitman JE. Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation. N Engl J Med. 1967;276(5):252–58. doi:10.1056/NEJM196702022760502.
  • Centres for Disease Control and Prevention (CDC). VPD surveillance manual. 5th ed. 2012. Chapter 9: Mumps. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt09-mumps.pdf.
  • Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, Fung C, Crowcroft NS. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ. 2011;183(9):1014–20. doi:10.1503/cmaj.101371.
  • Pang H, Zhou Y, Zhao W, Jiang Q. Seroprevalence and determinants associated with mumps antibodies after 20 years of MMR vaccination in urban area of Shanghai, China. Int J Environ Res Public Health. 2018;15(10):2089. doi:10.3390/ijerph15061188.
  • Su QR, Liu J, Ma C, Fan CX, Wen N, Luo HM, Wang HQ, Li L, Hao LX. Epidemic profile of mumps in China during 2004–2013. Zhonghua Yu Fang Yi Xue Za Zhi. 2016;50(7):611–14. In Chinese. doi:10.3760/cma.j.issn.0253-9624.2016.07.009.
  • Vygen S, Fischer A, Meurice L, Mounchetrou NI, Gregoris M, Ndiaye B, Ghenassia A, Poujol I, Stahl JP, Antona D, et al. Waning immunity against mumps in vaccinated young adults, France 2013. Euro Surveillance. 2016;21(10):30156. doi:10.2807/1560-7917.ES.2016.21.10.30156.
  • Clemmons NS, Redd SB, Gastanaduy PA, Marin M, Patel M, Fiebelkorn AP. Characteristics of large mumps outbreaks in the United States during July 2010-December 2015. Clin Infect Dis. 2018. doi:10.1093/cid/ciy779.
  • Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, et al. Mumps outbreak in orthodox Jewish communities in the United States. N Engl J Med. 2012;367(18):1704–13. doi:10.1056/NEJMoa1202865.
  • Sane J, Gouma S, Koopmans M, de Melker H, Swaan C, van Binnendijk R, Hahné S. Epidemic of mumps among vaccinated persons, The Netherlands, 2009–2012. Emerg Infect Dis. 2014;20(4):643–48. doi:10.3201/eid2004.131681.
  • Edmunds WJ, Gay NJ, Kretzschmar M, Pebody RG, Wachmann H. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect. 2000;125(3):635–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.